Regeneron Pharmaceuticals, Inc. (REGN)

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Let's take a close look at Gilead Sciences, Regeneron and Eli Lilly.

This is how you can tell which camp is winning and which is losing in this time of Covid-contradiction.

The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Markets are clearly different now. I did not grow up, nor was I trained for this environment. Nobody else you hear today was either.

I would wait until the next down day, and there will be one.

Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.

Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?

This list is not a buy list but a list of stocks that have been brought to new heights.

That's the really good news about why we could bounce back so quickly from Thursday's debacle.

The massive tock market drop was to be expected, and seasoned traders were prepared for it. But there was also some good news on the coronavirus vaccine/treatment front.

We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.

The RMPIA rose 3.2% for May and 3.3% for the first five months of 2020.

Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.

I get this rally -- it's based on more than a breaking branch this time, but there are still many uncertainties.

Use available weakness to go long or add to longs.

What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.

Don't just follow the herd, time your exits and entrances well -- even if it is a big player like Warren Buffett that is leading the charge.

It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.

For March and the first quarter, the RMPIA takes less of a hit than major indexes.

The five best performing and worst performing stocks in the S&P 500 in the previous quarter pretty much tells the tale of the tape, so here goes.

While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.

The drug and vaccine maker possibly could see its shares double according to a key chart.

I think our scientists, our medical minds, are working on an atomic bomb that can nuke Covid before it invades us.

The Fed has attacked developing problems in real-time -- and as China shows signs of life, the semi stocks are benefitting.